Exact Mass: 376.211

Exact Mass Matches: 376.211

Found 106 metabolites which its exact mass value is equals to given mass value 376.211, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Estradiol Benzoate

(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl) benzoate

C25H28O3 (376.2038)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents Same as: D01953

   

17beta-Hydroxy-7alpha-mercaptoandrost-4-en-3-one 7-propionate

17beta-Hydroxy-7alpha-mercaptoandrost-4-en-3-one 7-propionate

C22H32O3S (376.2072)


   

21-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione

6alpha-Methyl-11beta,17alpha-dihydroxy-21-fluoropregna-1,4-diene-3,20-dione

C22H29FO4 (376.205)


   

Etofenprox

1-{[2-(4-ethoxyphenyl)-2-methylpropoxy]methyl}-3-phenoxybenzene

C25H28O3 (376.2038)


D010575 - Pesticides > D007306 - Insecticides > D011722 - Pyrethrins

   

Desoximetasone

(1R,2S,10S,11S,13R,14S,15S,17S)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-3,6-dien-5-one

C22H29FO4 (376.205)


Desoximetasone is only found in individuals that have used or taken this drug. It is a topical anti-inflammatory glucocorticoid used in dermatoses, skin allergies, psoriasis, etc. [PubChem]The precise mechanism of the antiinflammatory activity of topical steroids in the treatment of steroid-responsive dermatoses, in general, is uncertain. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. This is achieved first by the drug binding to the glucocorticoid receptors which then translocates into the nucleus and binds to DNA causing various activations and repressions of genes. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XC - Corticosteroids, potent, other combinations D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents

   

Fluorometholone

(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-3,6-dien-5-one

C22H29FO4 (376.205)


Fluorometholone is only found in individuals that have used or taken this drug. It is a glucocorticoid employed, usually as eye drops, in the treatment of allergic and inflammatory conditions of the eye. It has also been used topically in the treatment of various skin disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732)There is no generally accepted explanation for the mechanism of action of ocular corticosteroids. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Their primary target is the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XB - Corticosteroids, moderately potent, other combinations S - Sensory organs > S01 - Ophthalmologicals > S01C - Antiinflammatory agents and antiinfectives in combination > S01CB - Corticosteroids/antiinfectives/mydriatics in combination D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AB - Corticosteroids, moderately potent (group ii) D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AA - Corticosteroids, combinations for treatment of acne C - Cardiovascular system > C05 - Vasoprotectives > C05A - Agents for treatment of hemorrhoids and anal fissures for topical use > C05AA - Corticosteroids D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents

   

Topisolon

1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one

C22H29FO4 (376.205)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids D000893 - Anti-Inflammatory Agents

   

estradiol benzoate

14-hydroxy-15-methyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-2,4,6-trien-5-yl benzoate

C25H28O3 (376.2038)


   

17beta-Estradiol benzoate

(3-Hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl) benzoate

C25H28O3 (376.2038)


   

Fluocortolone

6-Fluoro-11-hydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one

C22H29FO4 (376.205)


   

Fluoromethalone

14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one

C22H29FO4 (376.205)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents

   

Imigliptin

2-{[7-(3-aminopiperidin-1-yl)-3,5-dimethyl-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-1-yl]methyl}benzonitrile

C21H24N6O (376.2011)


   

TRISPHENOL

2-({2-hydroxy-3-[(2-hydroxy-3,5-dimethylphenyl)methyl]-5-methylphenyl}methyl)-4,6-dimethylphenol

C25H28O3 (376.2038)


   

2-(3,3-Dimethylallyl)-2,2-dimethylchromene (5,6:4,3)-4-hydroxy-5-methoxy stilbene

2-(3,3-Dimethylallyl)-2,2-dimethylchromene (5,6:4,3)-4-hydroxy-5-methoxy stilbene

C25H28O3 (376.2038)


   

Ovaliflavanone A

7-Hydroxy-6,8-di-C-prenylflavanone

C25H28O3 (376.2038)


   
   

Spinochalcone A

(E) -1- [ 2,4-Dihydroxy-3,5-bis (3-methyl-2-butenyl) phenyl ] -3-phenyl-2-propen-1-one

C25H28O3 (376.2038)


   

Cannabipiperidiethanone

Cannabipiperidiethanone

C24H28N2O2 (376.2151)


   

methyl 2-([1-(5-fluoropentyl)-1h-indole-3-carbonyl]amino)-3,3-dimethylbutanoate

methyl 2-([1-(5-fluoropentyl)-1h-indole-3-carbonyl]amino)-3,3-dimethylbutanoate

C21H29FN2O3 (376.2162)


   
   

N1,N3-Bis[(2,2-dimethylpropanoyl)oxy]-5-methylbenzene-1,3-dicarboximidamide

N1,N3-Bis[(2,2-dimethylpropanoyl)oxy]-5-methylbenzene-1,3-dicarboximidamide

C19H28N4O4 (376.211)


   

(E)-form-2,4-Dihydroxy-3,5-diprenylchalcone|2,4-dihydroxy-3,5-di-C-prenylchalcone|Spinochalcone A

(E)-form-2,4-Dihydroxy-3,5-diprenylchalcone|2,4-dihydroxy-3,5-di-C-prenylchalcone|Spinochalcone A

C25H28O3 (376.2038)


   

methyl-9R-(beta-D-glucopyranosyloxy)-cis-cascarillate|parisveroside B

methyl-9R-(beta-D-glucopyranosyloxy)-cis-cascarillate|parisveroside B

C18H32O8 (376.2097)


   

2,3-di-0-hexanoyl-alpha-glucopyranose

2,3-di-0-hexanoyl-alpha-glucopyranose

C18H32O8 (376.2097)


   

foliachinenoside G

foliachinenoside G

C18H32O8 (376.2097)


   

(E)-(xi)-2,6-dimethyl-8-hydroxyoct-2-enoic acid ethyl ester 8-O-beta-D-glucopyranoside|calophyloside A

(E)-(xi)-2,6-dimethyl-8-hydroxyoct-2-enoic acid ethyl ester 8-O-beta-D-glucopyranoside|calophyloside A

C18H32O8 (376.2097)


   

1-Demethylthio-1-hydroxy-lincomycin

1-Demethylthio-1-hydroxy-lincomycin

C17H32N2O7 (376.2209)


   

3-[4-hydroxy-3,5-bis(3-methylbut-2-enyl)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one

3-[4-hydroxy-3,5-bis(3-methylbut-2-enyl)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one

C25H28O3 (376.2038)


   
   
   
   

valylmethionyllysine

valylmethionyllysine

C16H32N4O4S (376.2144)


   

Fluorocortolone

Fluorocortolone

C22H29FO4 (376.205)


   
   
   

methionylvalyllysine

methionylvalyllysine

C16H32N4O4S (376.2144)


   
   
   

threonylthreonylarginine

threonylthreonylarginine

C14H28N6O6 (376.207)


   
   
   

Fluorometholone

Fluorometholone

C22H29FO4 (376.205)


   

(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one

"(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one"

C22H29FO4 (376.205)


   

MLS001076157-01!426-13-1

MLS001076157-01!426-13-1

C22H29FO4 (376.205)


   

MLS001076073-01!

MLS001076073-01!

C22H29FO4 (376.205)


   

Desoximetasone

Desoximetasone

C22H29FO4 (376.205)


D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XC - Corticosteroids, potent, other combinations D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents

   

Fluoromethalone

Fluoromethalone

C22H29FO4 (376.205)


D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XB - Corticosteroids, moderately potent, other combinations S - Sensory organs > S01 - Ophthalmologicals > S01C - Antiinflammatory agents and antiinfectives in combination > S01CB - Corticosteroids/antiinfectives/mydriatics in combination D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AB - Corticosteroids, moderately potent (group ii) D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AA - Corticosteroids, combinations for treatment of acne C - Cardiovascular system > C05 - Vasoprotectives > C05A - Agents for treatment of hemorrhoids and anal fissures for topical use > C05AA - Corticosteroids D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents CONFIDENCE standard compound; INTERNAL_ID 1168; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8875; ORIGINAL_PRECURSOR_SCAN_NO 8870 CONFIDENCE standard compound; INTERNAL_ID 1168; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8811; ORIGINAL_PRECURSOR_SCAN_NO 8809 CONFIDENCE standard compound; INTERNAL_ID 1168; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8911; ORIGINAL_PRECURSOR_SCAN_NO 8909 CONFIDENCE standard compound; INTERNAL_ID 1168; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8940; ORIGINAL_PRECURSOR_SCAN_NO 8939 CONFIDENCE standard compound; INTERNAL_ID 1168; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8959; ORIGINAL_PRECURSOR_SCAN_NO 8957 CONFIDENCE standard compound; INTERNAL_ID 1168; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8931; ORIGINAL_PRECURSOR_SCAN_NO 8930 CONFIDENCE standard compound; INTERNAL_ID 2811

   

Etofenprox

Etofenprox

C25H28O3 (376.2038)


D010575 - Pesticides > D007306 - Insecticides > D011722 - Pyrethrins CONFIDENCE standard compound; INTERNAL_ID 1039; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8875; ORIGINAL_PRECURSOR_SCAN_NO 8870 CONFIDENCE standard compound; INTERNAL_ID 1039; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8886; ORIGINAL_PRECURSOR_SCAN_NO 8883 CONFIDENCE standard compound; INTERNAL_ID 1039; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8911; ORIGINAL_PRECURSOR_SCAN_NO 8909 CONFIDENCE standard compound; INTERNAL_ID 1039; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8940; ORIGINAL_PRECURSOR_SCAN_NO 8939 CONFIDENCE standard compound; INTERNAL_ID 1039; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8959; ORIGINAL_PRECURSOR_SCAN_NO 8957 CONFIDENCE standard compound; INTERNAL_ID 1039; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8931; ORIGINAL_PRECURSOR_SCAN_NO 8930

   
   
   
   
   
   
   
   
   

Fluocortolone

Fluocortolone

C22H29FO4 (376.205)


H - Systemic hormonal preparations, excl. sex hormones and insulins > H02 - Corticosteroids for systemic use > H02A - Corticosteroids for systemic use, plain > H02AB - Glucocorticoids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XC - Corticosteroids, potent, other combinations C - Cardiovascular system > C05 - Vasoprotectives > C05A - Agents for treatment of hemorrhoids and anal fissures for topical use > C05AA - Corticosteroids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents

   

2,3-di-O-hexanoyl-alpha-glucopyranose

2,3-di-O-hexanoyl-alpha-glucopyranose

C18H32O8 (376.2097)


   

Trisphenol

2-[[2-Hydroxy-3-[(2-hydroxy-3,5-dimethylphenyl)methyl]-5-methylphenyl]methyl]-4,6-dimethylphenol

C25H28O3 (376.2038)


   

Benzenesulfonic acid, dodecyldimethyl-, sodium salt

Benzenesulfonic acid, dodecyldimethyl-, sodium salt

C20H33NaO3S (376.2048)


   

Tris((3-ethyl-3-oxetanyl)methyl) phosphite

Tris((3-ethyl-3-oxetanyl)methyl) phosphite

C18H33O6P (376.2015)


   

4,4-((2-HYDROXYPHENYL)METHYLENE)BIS(2,3,6-TRIMETHYLPHENOL)

4,4-((2-HYDROXYPHENYL)METHYLENE)BIS(2,3,6-TRIMETHYLPHENOL)

C25H28O3 (376.2038)


   

6-(1-Oxo-3-(4-benzyl-1-piperidyl)propyl)-3,4-dihydrocarbostyril

6-(1-Oxo-3-(4-benzyl-1-piperidyl)propyl)-3,4-dihydrocarbostyril

C24H28N2O2 (376.2151)


   
   

2,6-bis[(4-hydroxy-3,5-dimethylphenyl)methyl]-4-methylphenol

2,6-bis[(4-hydroxy-3,5-dimethylphenyl)methyl]-4-methylphenol

C25H28O3 (376.2038)


   
   

(2S)-2-[[(2S)-2-Cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoic acid

(2S)-2-[[(2S)-2-Cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoic acid

C19H28N4O4 (376.211)


   

3,9-Diazaspiro[5.5]undecane-3-carboxylic acid, 9H-fluoren-9-ylmethyl ester

3,9-Diazaspiro[5.5]undecane-3-carboxylic acid, 9H-fluoren-9-ylmethyl ester

C24H28N2O2 (376.2151)


   

Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 3-benzoate

Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 3-benzoate

C25H28O3 (376.2038)


   

6alpha-Methyl-11beta,17alpha-dihydroxy-21-fluoropregna-1,4-diene-3,20-dione

6alpha-Methyl-11beta,17alpha-dihydroxy-21-fluoropregna-1,4-diene-3,20-dione

C22H29FO4 (376.205)


   

((4,6-Bis(bis(methoxymethyl)amino)-1,3,5-triazin-2-yl)(methoxymethyl)amino)methanol

((4,6-Bis(bis(methoxymethyl)amino)-1,3,5-triazin-2-yl)(methoxymethyl)amino)methanol

C14H28N6O6 (376.207)


   
   

N-[2-(4-ethyl-1-piperazinyl)-4-methyl-6-quinolinyl]-2-pyrazinecarboxamide

N-[2-(4-ethyl-1-piperazinyl)-4-methyl-6-quinolinyl]-2-pyrazinecarboxamide

C21H24N6O (376.2011)


   

N(6)-(L-homocysteinyl)-L-lysyl-L-leucine

N(6)-(L-homocysteinyl)-L-lysyl-L-leucine

C16H32N4O4S (376.2144)


   
   
   
   
   

N-[(2R,3R,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)oxan-3-yl]cyclohexanecarboxamide

N-[(2R,3R,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)oxan-3-yl]cyclohexanecarboxamide

C17H32N2O5S (376.2032)


   

N-[(2S,3S,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]cyclohexanecarboxamide

N-[(2S,3S,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]cyclohexanecarboxamide

C17H32N2O5S (376.2032)


   

N-[[(2S,3R,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-phenylacetamide

N-[[(2S,3R,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-phenylacetamide

C24H28N2O2 (376.2151)


   

N-[(2R,3R,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]cyclohexanecarboxamide

N-[(2R,3R,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]cyclohexanecarboxamide

C17H32N2O5S (376.2032)


   
   
   
   
   
   
   

1-[2,4-dihydroxy-3,5-bis(3-methylbut-2-en-1-yl)phenyl]-3-phenylprop-2-en-1-one

1-[2,4-dihydroxy-3,5-bis(3-methylbut-2-en-1-yl)phenyl]-3-phenylprop-2-en-1-one

C25H28O3 (376.2038)


   

4-methoxy-3,5-dimethyl-6-[(2e,4z,6z)-7-[4-methyl-2-(prop-2-en-1-yl)phenyl]hepta-2,4,6-trien-1-yl]pyran-2-one

4-methoxy-3,5-dimethyl-6-[(2e,4z,6z)-7-[4-methyl-2-(prop-2-en-1-yl)phenyl]hepta-2,4,6-trien-1-yl]pyran-2-one

C25H28O3 (376.2038)


   

3-[4-hydroxy-3,5-bis(3-methylbut-2-en-1-yl)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one

3-[4-hydroxy-3,5-bis(3-methylbut-2-en-1-yl)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one

C25H28O3 (376.2038)


   

3-(hexanoyloxy)-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl hexanoate

3-(hexanoyloxy)-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl hexanoate

C18H32O8 (376.2097)


   

(2e)-3-[4-hydroxy-3,5-bis(3-methylbut-2-en-1-yl)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one

(2e)-3-[4-hydroxy-3,5-bis(3-methylbut-2-en-1-yl)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one

C25H28O3 (376.2038)


   

bis[(4z)-2,2,6-trimethyl-3h-1-benzopyran-4-ylidene]hydrazine

bis[(4z)-2,2,6-trimethyl-3h-1-benzopyran-4-ylidene]hydrazine

C24H28N2O2 (376.2151)


   

4-hydroxy-3,5-dimethyl-6-[(2e,4z,6z)-3-methyl-7-[4-methyl-2-(prop-2-en-1-yl)phenyl]hepta-2,4,6-trien-1-yl]pyran-2-one

4-hydroxy-3,5-dimethyl-6-[(2e,4z,6z)-3-methyl-7-[4-methyl-2-(prop-2-en-1-yl)phenyl]hepta-2,4,6-trien-1-yl]pyran-2-one

C25H28O3 (376.2038)


   

[(1r,2s,3s)-2-[(2e)-pent-2-en-1-yl]-3-{[(2s,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]oxy}cyclopentyl]acetic acid

[(1r,2s,3s)-2-[(2e)-pent-2-en-1-yl]-3-{[(2s,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]oxy}cyclopentyl]acetic acid

C18H32O8 (376.2097)


   

4-hydroxy-3,5-dimethyl-6-{3-methyl-7-[4-methyl-2-(prop-2-en-1-yl)phenyl]hepta-2,4,6-trien-1-yl}pyran-2-one

4-hydroxy-3,5-dimethyl-6-{3-methyl-7-[4-methyl-2-(prop-2-en-1-yl)phenyl]hepta-2,4,6-trien-1-yl}pyran-2-one

C25H28O3 (376.2038)


   

(2s,3r,4s,5r,6r)-4-(hexanoyloxy)-2,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl hexanoate

(2s,3r,4s,5r,6r)-4-(hexanoyloxy)-2,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl hexanoate

C18H32O8 (376.2097)


   

[(4e)-2,2,6-trimethyl-3h-1-benzopyran-4-ylidene][(4z)-2,2,6-trimethyl-3h-1-benzopyran-4-ylidene]hydrazine

[(4e)-2,2,6-trimethyl-3h-1-benzopyran-4-ylidene][(4z)-2,2,6-trimethyl-3h-1-benzopyran-4-ylidene]hydrazine

C24H28N2O2 (376.2151)


   

4-[(1e)-2-[5-methoxy-2,2-dimethyl-8-(3-methylbut-2-en-1-yl)chromen-7-yl]ethenyl]phenol

4-[(1e)-2-[5-methoxy-2,2-dimethyl-8-(3-methylbut-2-en-1-yl)chromen-7-yl]ethenyl]phenol

C25H28O3 (376.2038)


   

(5r)-5-(8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octyl)oxolan-2-one

(5r)-5-(8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octyl)oxolan-2-one

C18H32O8 (376.2097)


   

4-methoxy-3,5-dimethyl-6-{7-[4-methyl-2-(prop-2-en-1-yl)phenyl]hepta-2,4,6-trien-1-yl}pyran-2-one

4-methoxy-3,5-dimethyl-6-{7-[4-methyl-2-(prop-2-en-1-yl)phenyl]hepta-2,4,6-trien-1-yl}pyran-2-one

C25H28O3 (376.2038)


   

bis(2,2,6-trimethyl-3h-1-benzopyran-4-ylidene)hydrazine

bis(2,2,6-trimethyl-3h-1-benzopyran-4-ylidene)hydrazine

C24H28N2O2 (376.2151)


   

[2-(pent-2-en-1-yl)-3-[(2,3,4,5,6-pentahydroxyhexyl)oxy]cyclopentyl]acetic acid

[2-(pent-2-en-1-yl)-3-[(2,3,4,5,6-pentahydroxyhexyl)oxy]cyclopentyl]acetic acid

C18H32O8 (376.2097)


   

bis[(4e)-2,2,6-trimethyl-3h-1-benzopyran-4-ylidene]hydrazine

bis[(4e)-2,2,6-trimethyl-3h-1-benzopyran-4-ylidene]hydrazine

C24H28N2O2 (376.2151)